• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion.

作者信息

Robinson Andrea, Billakanty Sreedhar, Fu Eugene, Amin Anish

机构信息

OhioHealth Heart and Vascular Physicians, Section of Cardiac Electrophysiology, Department of Cardiology, Riverside Methodist Hospital, Columbus, Ohio.

出版信息

Heart Rhythm O2. 2024 Mar 10;5(4):243-245. doi: 10.1016/j.hroo.2024.02.007. eCollection 2024 Apr.

DOI:10.1016/j.hroo.2024.02.007
PMID:38690143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11056457/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/11056457/e1faee2ed68c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/11056457/e1faee2ed68c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/11056457/e1faee2ed68c/gr1.jpg

相似文献

1
Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion.一名反复出现经静脉植入式心律转复除颤器侵蚀的患者成功进行了血管外植入式心律转复除颤器植入术。
Heart Rhythm O2. 2024 Mar 10;5(4):243-245. doi: 10.1016/j.hroo.2024.02.007. eCollection 2024 Apr.
2
Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options.非传统型植入式心脏复律除颤器的配置和插入技术：当代选择的回顾。
Europace. 2022 Feb 2;24(2):181-192. doi: 10.1093/europace/euab178.
3
Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.皮下与传统心脏除颤器的疗效和并发症：系统评价和荟萃分析。
Curr Cardiol Rev. 2022;18(3):e081221198647. doi: 10.2174/1573403X17666211208100151.
4
The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.需要在植入皮下植入式心律转复除颤器的患者中使用后续的经静脉系统。
Heart Rhythm. 2022 Dec;19(12):1958-1964. doi: 10.1016/j.hrthm.2022.06.030. Epub 2022 Jun 30.
5
Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.经皮心内膜下心导管取出术在咨询下进行——比较 Riata、Sprint Fidelis 和未召回的植入式心脏复律除颤器导线。
Heart Rhythm. 2013 Oct;10(10):1444-50. doi: 10.1016/j.hrthm.2013.06.021. Epub 2013 Jun 28.
6
Implantable transvenous cardioverter-defibrillators.植入式经静脉心脏复律除颤器
Circulation. 1993 Apr;87(4):1152-68. doi: 10.1161/01.cir.87.4.1152.
7
Subcutaneous implantable cardioverter defibrillator after transvenous lead extraction: safety, efficacy and outcome.经静脉导线拔除术后皮下植入式心律转复除颤器：安全性、有效性及结果
J Interv Card Electrophysiol. 2025 Oct;68(7):1399-1407. doi: 10.1007/s10840-022-01293-y. Epub 2022 Jul 13.
8
Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum.皮下植入式心律转复除颤器在一名患有漏斗胸的日本患者体内成功进行肌间植入。
J Arrhythm. 2017 Feb;33(1):63-65. doi: 10.1016/j.joa.2016.04.005. Epub 2016 Jun 1.
9
Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.经静脉植入式心脏复律除颤器（ICD）取出后皮下植入式 ICD 的使用和结局：对当前临床实践的分析及与经静脉 ICD 再植入的比较。
Heart Rhythm. 2019 Apr;16(4):564-571. doi: 10.1016/j.hrthm.2018.10.026. Epub 2018 Oct 24.
10
Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction.经静脉导线拔除后皮下植入式心律转复除颤器的性能和结果。
Pacing Clin Electrophysiol. 2021 Feb;44(2):247-257. doi: 10.1111/pace.14157. Epub 2021 Jan 12.

本文引用的文献

1
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.经静脉植入式心脏复律除颤器的疗效和安全性。
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
2
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study.皮下植入式心律转复除颤器患者的感染：S-ICD 上市后研究结果。
Heart Rhythm. 2022 Dec;19(12):1993-2001. doi: 10.1016/j.hrthm.2022.07.031. Epub 2022 Aug 6.
3
Risk Factors for CIED Infection After Secondary Procedures: Insights From the WRAP-IT Trial.
二次手术后心脏植入电子设备感染的危险因素：WRAP-IT 试验的见解。
JACC Clin Electrophysiol. 2022 Jan;8(1):101-111. doi: 10.1016/j.jacep.2021.08.009. Epub 2021 Sep 29.
4
Subcutaneous or Transvenous Defibrillator Therapy.皮下或经静脉除颤器治疗。
N Engl J Med. 2020 Aug 6;383(6):526-536. doi: 10.1056/NEJMoa1915932.
5
Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.抗菌包膜预防心脏植入式电子设备感染。
N Engl J Med. 2019 May 16;380(20):1895-1905. doi: 10.1056/NEJMoa1901111. Epub 2019 Mar 17.
6
Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.预防心律失常装置感染试验：PADIT 试验。
J Am Coll Cardiol. 2018 Dec 18;72(24):3098-3109. doi: 10.1016/j.jacc.2018.09.068.
7
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.2017年心律学会心血管植入式电子装置导线管理与拔除专家共识声明
Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15.
8
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.完全皮下植入式除颤器的安全性和有效性：IDE 研究和 EFFORTLESS 注册研究的汇总分析 2 年结果。
J Am Coll Cardiol. 2015 Apr 28;65(16):1605-1615. doi: 10.1016/j.jacc.2015.02.047.
9
The subcutaneous defibrillator: a review of the literature.皮下除颤器：文献回顾。
J Am Coll Cardiol. 2014 Apr 22;63(15):1473-9. doi: 10.1016/j.jacc.2014.01.018. Epub 2014 Feb 12.
10
Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution.完全皮下植入式心脏除颤器在儿童和成人中的临床应用经验：需要谨慎。
Eur Heart J. 2012 Jun;33(11):1351-9. doi: 10.1093/eurheartj/ehs017. Epub 2012 Mar 8.